Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Authors’ Reply
BRIDGING THE GAP
BRIEF COMMUNICATION
BRIEF REPORT
Case Report
Case Reports
Case Series
CME
CME ARTICLE
CME articles - Practice points
COMMENTARY
CONFERENCE REPORT
Consensus Statement
CONTROVERSY
Correspondence
Correspondences
CUTANEOUS PATHOLOGY
DRUG REVIEW
E-CHAT
Editorial
EDITORIAL COMMENTARY
EDITORIAL CORRECTION
ERRATUM
ETHICAL HOTLINE
ETHICS
Field: Evolution of dermatologic surgergy
FOCUS
FROM THE ARCHIVES OF INDIAN JOURNAL OF DERMATO SURGERY
From the Editor's Desk
FROM THE LITERATURE
GUEST EDITORIAL
Guidelines
Image
Images in Clinical Practice
Images in Dermatosurgery
INNOVATION
Innovations
INVITED COMMENTARY
JCAS Symposium
LETTER
Letter to Editor
Letter to the Editor
LETTERS
Media & News
Message from the President
NEW HORIZON
Original Article
Point of View
Practice Point
Practice Points
PRESIDENTIAL SPEECH
QUIZ
RESEARCH ARTICLE
Resident’s Page
Review
Review Article
Review Articles
SHORT COMMUNICATION
Spot the Diagnosis [Quiz]
STUDY
SURGICAL PEARL
SYMPOSIUM
Symposium—Lasers
Symposium: Hair in Dermatology
Symposium: Lasers Review Article
View Point
VIEWPOINT
VIEWPOINTS
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Authors’ Reply
BRIDGING THE GAP
BRIEF COMMUNICATION
BRIEF REPORT
Case Report
Case Reports
Case Series
CME
CME ARTICLE
CME articles - Practice points
COMMENTARY
CONFERENCE REPORT
Consensus Statement
CONTROVERSY
Correspondence
Correspondences
CUTANEOUS PATHOLOGY
DRUG REVIEW
E-CHAT
Editorial
EDITORIAL COMMENTARY
EDITORIAL CORRECTION
ERRATUM
ETHICAL HOTLINE
ETHICS
Field: Evolution of dermatologic surgergy
FOCUS
FROM THE ARCHIVES OF INDIAN JOURNAL OF DERMATO SURGERY
From the Editor's Desk
FROM THE LITERATURE
GUEST EDITORIAL
Guidelines
Image
Images in Clinical Practice
Images in Dermatosurgery
INNOVATION
Innovations
INVITED COMMENTARY
JCAS Symposium
LETTER
Letter to Editor
Letter to the Editor
LETTERS
Media & News
Message from the President
NEW HORIZON
Original Article
Point of View
Practice Point
Practice Points
PRESIDENTIAL SPEECH
QUIZ
RESEARCH ARTICLE
Resident’s Page
Review
Review Article
Review Articles
SHORT COMMUNICATION
Spot the Diagnosis [Quiz]
STUDY
SURGICAL PEARL
SYMPOSIUM
Symposium—Lasers
Symposium: Hair in Dermatology
Symposium: Lasers Review Article
View Point
VIEWPOINT
VIEWPOINTS
View/Download PDF
Review Article
ARTICLE IN PRESS
doi:
10.25259/JCAS_321_2025

Translate:

Lasers in pediatric dermatology: Current indications, safety, and evolving perspectives

Author affiliations
Department of Dermatology and STD, Vardhman Mahavir Medical College and Safdarjung Hospital, Delhi, India.
Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Article History
Corresponding author(s)

*Corresponding author: Rashmi Sarkar, Department of Dermatology and STD, Vardhman Mahavir Medical College and Safdarjung Hospital, Delhi, India. rashmisarkar@gmail.com

Article tools · PDF & citations

Abstract

Lasers have become an integral component of pediatric dermatology, offering precise and minimally invasive treatments for a range of vascular, pigmented, and scarring conditions. Their use in children, however, requires special consideration owing to unique anatomical and physiological features of pediatric skin, including thinner epidermis, higher water content, and greater melanocyte activity. Pulsed dye laser remains the treatment of choice for vascular lesions such as port-wine stains and infantile hemangiomas, while Q-switched and picosecond lasers are preferred for pigmented lesions, including nevus of Ota, café-au-lait macules, and tattoos. Fractional lasers have expanded therapeutic options for scars, burns, and acne scars, with favorable safety profiles in skin of color. Pain, pigmentary alterations, epidermal damage, and infection are the most common adverse effects, underscoring the importance of conservative laser settings, cooling techniques, and vigilant aftercare. Recent advances, such as combination laser protocols, integration with pharmacologic therapy, and fractional technologies, have further optimized outcomes. Despite these advances, challenges remain due to the lack of standardized pediatric protocols, limited long-term safety data, and the underrepresentation of children in clinical trials. This narrative review was prepared by conducting a broad literature search on PubMed, Medline, Embase, Scopus, and Google Scholar for articles related to the use of lasers in pediatric dermatology, published between January 2000 and October 2025. Keywords such as “pediatric dermatology,” “children,” “laser therapy,” “vascular lasers,” “pigment lasers,” and “fractional lasers” were used. Overall, lasers provide safe and effective management of pediatric dermatoses when used judiciously, with individualized protocols tailored to patient age, skin type, and lesion characteristics.

Keywords

  • Lasers
  • Nevi
  • Pediatric dermatology
  • Pediatrics
  • Pigmentation
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Sarkar R, Gupta M. Lasers in pediatric dermatology: Current indications, safety, and evolving perspectives. J Cutan Aesthet Surg. doi: 10.25259/JCAS_321_2025

INTRODUCTION

Since the advent of lasers in dermatology by Dr. Leon Goldman in 1963, laser surgery has revolutionized how we treat multiple skin conditions, including pediatric dermatoses.1 Unlike in adults, performing procedures in the pediatric population of varying age groups does carry a different set of challenges. In this review, we discuss common indications for dermatologic lasers in our Asian pediatric population and focus on special considerations and tips for treating this particular group of patients. The neodymium-doped yttrium aluminium garnet (Nd:YAG) and pulsed dye lasers (PDLs) are discussed in detail due to their widespread availability and frequent use in clinical practice.

METHODOLOGY

This narrative review was based on a structured literature search of PubMed, MEDLINE, Embase, Scopus, and Google Scholar for studies published between January 2000 and October 2025. Search terms included “pediatric dermatology,” “children,” “laser therapy,” “pulsed dye laser,” “Nd:YAG,” “fractional lasers,” and related keywords.

Studies were included if they involved patients ≤18 years and evaluated laser therapy for dermatologic conditions, reporting outcomes related to efficacy, safety, or procedural parameters. Eligible study designs included clinical trials, observational studies, case series, systematic reviews, and guidelines. Studies involving only adults, non-dermatologic indications, insufficient data, duplicates, or non-full-text articles were excluded.

A total of 90 records were identified, of which 56 studies were included after screening and full-text review. Priority was given to studies with robust clinical outcomes and relevance to pediatric skin, particularly skin of color. Given the limited number of pediatric randomized controlled trials in laser dermatology, high-quality observational studies and expert recommendations were also incorporated where clinically relevant. Greater emphasis was placed on studies reporting standardized laser parameters, safety outcomes, and pediatric-specific considerations.

The evidence was interpreted according to an evidence hierarchy, with systematic reviews and meta-analyses considered highest-level evidence, followed by randomized controlled trials, cohort and observational studies, case series, and expert opinion or consensus guidelines. Due to the limited availability of pediatric randomized trials in laser dermatology, findings from high-quality observational studies and expert recommendations were also incorporated.

The findings were synthesized descriptively and organized according to laser type, clinical indication, safety profile, and pediatric-specific considerations.

PRINCIPLES OF LASER USE IN CHILDREN

Laser therapy in pediatric dermatology is based on selective photothermolysis, where specific wavelengths target chromophores such as melanin, hemoglobin, and water to achieve precise tissue destruction with minimal collateral damage.2 Pediatric patients require special consideration due to distinct anatomical and physiological characteristics of their skin [Table 1 and Flowchart 1].3

Table 1: Key differences between pediatric and adult skin in laser therapy.
Parameter Pediatric skin Adult skin Clinical implication
Water content Higher Lower Greater risk of deeper thermal injury with CO2/ Er:YAG
Epidermal thickness Thinner Thicker Increased risk of blistering, PIH
Melanocyte activity Higher Lower More pigmentary complications in children
Healing capacity Faster Slower Earlier intervention yields better outcomes

PIH: Post-inflammatory hyperpigmentation, Er: YAG: Erbium-doped yttrium aluminium garnet

Clinical decision algorithm for pediatric laser therapy. Stepwise approach incorporating evaluation, risk stratification, treatment selection, and post-procedure care to ensure safe and effective outcomes in children. (PIH: Post-inflammatory hyperpigmentation, HSV: Herpes simplex virus).
Flowchart 1: Clinical decision algorithm for pediatric laser therapy. Stepwise approach incorporating evaluation, risk stratification, treatment selection, and post-procedure care to ensure safe and effective outcomes in children. (PIH: Post-inflammatory hyperpigmentation, HSV: Herpes simplex virus).

LASER TISSUE INTERACTION FUNDAMENTALS

Laser efficacy and safety depend on parameters such as wavelength, pulse duration, and fluence. Wavelength determines chromophore specificity, pulse duration should correspond to the target’s thermal relaxation time, and fluence must be carefully adjusted in children to avoid overtreatment due to thinner skin.4 In addition, spot size and repetition rate affect the depth of laser penetration and overall treatment efficiency.5,6

UNIQUE ASPECTS OF PEDIATRIC SKIN

Higher water content

Pediatric skin has a higher proportion of water compared to adult skin, particularly in the dermis.7 This makes water-targeting lasers (e.g., carbon dioxide [CO2] or Er:YAG) more effective but also increases the risk of deeper thermal injury if parameters are not appropriately adjusted.

Greater susceptibility to pigmentary alterations

The melanocyte activity in children is relatively high, and the epidermis is thinner, leading to increased risk of post-inflammatory hyperpigmentation (PIH).8 Therefore, Q-switched (QS) lasers, often used for pigmented lesions, must be used with conservative settings (especially in Fitzpatrick IV–VI skin types).9

Faster healing and regeneration

Children demonstrate faster epidermal turnover, enhanced collagen remodeling, and more efficient wound healing than adults.10 This makes children ideal candidates for early laser intervention, particularly for vascular malformations such as port-wine stains (PWS) and hemangiomas, with earlier treatment often requiring fewer sessions and producing superior functional and cosmetic outcomes.11

CLINICAL INDICATIONS FOR LASER THERAPY IN PEDIATRICS

Vascular lesions

Indications

Vascular lesions are among the most common indications for pediatric laser therapy, including PWS, infantile hemangiomas (IH), telangiectasias, angiokeratomas, and angioma serpiginosum. Hemoglobin serves as the primary chromophore, making the (PDL; 585–595 nm) the treatment of choice [Tables 2 and 3].12

Table 2: Common pediatric indications for lasers and preferred devices.
Condition Preferred laser Wavelength (nm) Notes
Port-wine stain Pulsed dye laser 585–595 Early treatment (<6 months) best outcomes
Infantile hemangioma PDL (± propranolol) 595 Ulcerated/residual lesions
Nevus of Ota/Ito Picosecond Nd:YAG, Alexandrite 755–1064 Earlier response, fewer sessions
CALMs QS Nd:YAG 1064 Higher recurrence, better for “Coast of Maine” subtype
Scars (surgical/burn) Fractional lasers 1550 Er-glass >75% improvement after 1 session
Warts PDL/Nd:YAG 585/1064 Clearance 50–95%
Acne scars Fractional Er-glass 1550 Safe in skin of color

PDL: Pulsed dye lasers, CALMs : Café-au-lait macules, Nd: YAG: Neodymium-doped yttrium aluminium garnet, QS: Q-switched

Table 3: Comparative table of laser modalities.
Laser Chromophore Depth Indications Advantages Limitations
PDL Hemoglobin Superficial PWS, IH Gold standard Purpura
Nd:YAG (1064 nm) Hemoglobin/melanin Deep Warts, pigment Safer in dark skin Less selective
QS lasers Melanin Dermal Nevus of Ota Established efficacy Multiple sessions
Picosecond Melanin Dermal Tattoos, Ota Faster clearance Cost
Fractional lasers Water Variable Scars Remodeling Multiple sessions
CO2 laser Water Ablative Keloids Precision Downtime

PDL: Pulsed dye lasers, QS: Q-switched, PWS: Port wine stain, IH: Infantile hemangioma, Nd: YAG : Neodymium-doped yttrium aluminium garnet,

Evidence

PWS occur in 0.3–0.5% of neonates, predominantly involving the head and neck, and may be associated with syndromes such as PROS or Sturge–Weber.12 They present as flat erythematous patches that progressively darken and thicken with age. Early intervention (<6 months) is associated with superior outcomes due to smaller vessel size, reduced melanin interference, and higher fetal hemoglobin levels, achieving clearance rates of up to 89% in selected studies.13-15

IH follow a characteristic course of proliferation, involution, and quiescence. PDL is most effective for superficial lesions, ulcerated hemangiomas (often combined with propranolol), and residual telangiectatic components after involution.16-18 Additional vascular lesions such as telangiectasias, angiokeratomas, and angioma serpiginosum have also demonstrated favorable responses to PDL therapy.19,20

Parameters

For PWS, optimal PDL settings include:

  • Wavelength: 585–595 nm

  • Spot size: 7–10 mm

  • Fluence: 7–9 J/cm2

  • Pulse duration: 0.45–1.5 ms

  • Overlap: 10–20%

  • Treatment interval: 2–4 weeks.14

For Infantile hemangiomas (IH):

  • Spot size: 7–10 mm

  • Pulse duration: 0.45–1.5 ms

  • Fluence: 7–12 J/cm2 (superficial lesions)

  • Fluence: 5–8 J/cm2 (ulcerated lesions).16-18

Epidermal cooling is essential to minimize thermal injury.19

Outcomes

PDL treatment leads to a significant reduction in erythema and lesion thickness. Early treatment improves response rates and reduces the number of sessions required, with clearance rates approaching 80–90% in selected cases.13 Outcomes vary by anatomical location, with mid-forehead lesions responding best and centrofacial lesions showing relative resistance.15 In IH, PDL promotes healing of ulceration and improves residual vascular changes.

Limitations

Multiple sessions are often required, and complete clearance may not always be achieved, particularly in hypertrophic or nodular PWS.15 Adverse effects include purpura, erythema, edema, blistering, pain, and pigmentary alterations. Darker skin types carry a higher risk of dyspigmentation, necessitating lower fluence, longer pulse durations, extended treatment intervals, and strict epidermal cooling.19 Resistant or deeper lesions may require longer wavelengths or combination approaches.

Pigmented lesions

Indication

Laser therapy for pigmented lesions is based on the principle of selective photothermolysis, targeting melanin as the primary chromophore.2 Common pediatric indications include nevus of Ota/Ito, café-au-lait macules (CALMs), lentigines, tattoos, and Becker’s nevus.

Evidence

Melanin absorbs light across a broad spectrum (250–1200 nm), with preferential absorption in the 620–1100 nm range.21 Its thermal relaxation time (250–1000 ns) necessitates energy delivery in the nanosecond to picosecond (PS) range, making QS and PS lasers ideal.

Nevus of Ota and Ito are dermal melanocytoses presenting as blue–grey pigmentation, often persistent and cosmetically significant.22,23 Studies demonstrate that PS lasers (755 nm alexandrite, 1064 nm Nd:YAG) provide superior clearance with fewer sessions and reduced adverse effects compared to QS lasers.24,25

CALMs are common benign lesions, with response to laser therapy being variable and recurrence rates up to 50%.26 Morphology influences outcomes, with irregular (“Coast of Maine”) lesions responding better than smooth-bordered variants. A meta-analysis reported ≥50% clearance in 75% of patients and ≥75% clearance in 43.3%, with QS 1064 nm Nd:YAG offering an optimal balance of efficacy and safety.26,27

Tattoo removal in children is increasingly sought, with efficacy depending on pigment characteristics [Figures 1a and b]. PS lasers demonstrate faster clearance compared to QS lasers, particularly for multicolored tattoos.28

(a and b) Nd:YAG laser treatment of tattoo. (a) Pre-treatment photograph of a 15-year-old patient showing tattoo over the forearm. (b) Post-treatment image following 5 sessions of Q-switched Nd:YAG laser (1064 nm; fluence 1–2 J/cm2; spot size 3–5 mm) showing marked lightening of pigment with preservation of surrounding skin (Nd: YAG: Neodymium-doped yttrium aluminium garnet)
Figure 1: (a and b) Nd:YAG laser treatment of tattoo. (a) Pre-treatment photograph of a 15-year-old patient showing tattoo over the forearm. (b) Post-treatment image following 5 sessions of Q-switched Nd:YAG laser (1064 nm; fluence 1–2 J/cm2; spot size 3–5 mm) showing marked lightening of pigment with preservation of surrounding skin (Nd: YAG: Neodymium-doped yttrium aluminium garnet)

Becker’s nevus [Figures 2a and b], an epidermal hamartoma, may respond to Er:YAG lasers, although the risk of pigmentary alteration and scarring remains.29,30

(a and b) Long-pulsed Nd:YAG laser for Becker’s nevus. (a) Baseline clinical photograph of the lower leg of a 16-year-old patient showing diffuse perifollicular hyperpigmentation with coarse terminal hair. (b) Post-treatment image after 4 sessions of long-pulsed Nd:YAG laser (1064 nm; fluence 2–3 J/cm2; spot size 6 mm) demonstrating reduction in pigmentation. (Nd: YAG: Neodymium-doped yttrium aluminium garnet)
Figure 2: (a and b) Long-pulsed Nd:YAG laser for Becker’s nevus. (a) Baseline clinical photograph of the lower leg of a 16-year-old patient showing diffuse perifollicular hyperpigmentation with coarse terminal hair. (b) Post-treatment image after 4 sessions of long-pulsed Nd:YAG laser (1064 nm; fluence 2–3 J/cm2; spot size 6 mm) demonstrating reduction in pigmentation. (Nd: YAG: Neodymium-doped yttrium aluminium garnet)

Lentigines [Figures 3a and b] respond well to QS melanin-selective lasers (532 nm Nd:YAG, ruby, alexandrite) with minimal collateral damage.31-33

(a and b) Low-fluence Nd:YAG laser for facial freckles (lentigines). (a) Pre-treatment clinical photograph of a 17-year-old female showing multiple discrete facial freckles (lentigines) predominantly over the malar region. (b) Post-treatment image after 6 sessions of low-fluence Nd:YAG laser (1064 nm; fluence 1–2 J/cm2; spot size 3–4 mm) demonstrating significant lightening of freckles with uniform facial skin tone and no post-inflammatory dyspigmentation. (Nd: YAG: Neodymium-doped yttrium aluminium garnet)
Figure 3: (a and b) Low-fluence Nd:YAG laser for facial freckles (lentigines). (a) Pre-treatment clinical photograph of a 17-year-old female showing multiple discrete facial freckles (lentigines) predominantly over the malar region. (b) Post-treatment image after 6 sessions of low-fluence Nd:YAG laser (1064 nm; fluence 1–2 J/cm2; spot size 3–4 mm) demonstrating significant lightening of freckles with uniform facial skin tone and no post-inflammatory dyspigmentation. (Nd: YAG: Neodymium-doped yttrium aluminium garnet)

Parameters

  • QS/PS lasers: Nanosecond– PS pulse duration for melanin targeting

  • Nevus of Ota/Ito: 755 nm (alexandrite), 1064 nm (Nd:YAG)23

  • CALMs: QS Nd:YAG 1064 nm preferred.26

  • Tattoo removal:

    • 532 nm → red/yellow/orange

    • 755–785 nm → green/blue/purple

    • 755–1064 nm → dark pigments.28

  • Lentigines: QS 532/1064 nm Nd:YAG, ruby, alexandrite31

  • Treatment interval: typically 6–8 weeks

  • Test spots recommended in darker phototypes.

Outcomes

QS and PS lasers achieve significant pigment clearance, with PS lasers offering faster results, fewer sessions, and reduced pigmentary complications.24,25 CALMs demonstrate moderate response with variable recurrence, while lentigines show excellent clearance rates. Tattoo removal requires multiple sessions but yields progressive pigment reduction. Early intervention improves outcomes in dermal melanocytosis.

Limitations

Multiple sessions are required, and recurrence is common in CALMs. Adverse effects include PIH, hypopigmentation, blistering, and rarely scarring. Darker skin types have a higher risk of dyspigmentation, necessitating conservative parameters and test spots. Deeper lesions may respond incompletely, and treatment outcomes vary with lesion morphology and depth.

OTHER INDICATIONS

Warts

Laser therapy targets wart blood vessels via photothermal or photomechanical destruction of vessel structures. 585 nm PDL achieves clearance rates above 95% for simple warts, with recalcitrant lesions showing variability from 50% to 100% and recurrence rates of 0–15% in pediatric populations.34 In addition, long-pulsed 1064 nm Nd:YAG laser has shown effectiveness in treating palmoplantar warts, achieving clearance in about 73% of cases, with only ~5% developing hemorrhagic blisters and no relapses at 3–6-month follow-up.35

Scars (Surgical, burn)

Non-ablative fractional photothermolysis by erbium-glass lasers —particularly at 1550 nm—is effective in improving surgical scars. Case reports demonstrate >75% clinical improvement after a single session with minimal side effects and sustained benefit at 1-month follow-up [Figures 4a and b].36

(a and b) Fractional CO2 laser resurfacing for traumatic scar. (a) Pre-treatment photograph of a 14-year-old male with scar on forehead (black arrow) (b) Post-treatment image after 5 sessions of fractional CO2 laser (10,600 nm; energy 15–20 mJ/microbeam; density 5–10%; single pass) showing improvement in surface texture, and overall cosmetic outcome(black arrow).
Figure 4: (a and b) Fractional CO2 laser resurfacing for traumatic scar. (a) Pre-treatment photograph of a 14-year-old male with scar on forehead (black arrow) (b) Post-treatment image after 5 sessions of fractional CO2 laser (10,600 nm; energy 15–20 mJ/microbeam; density 5–10%; single pass) showing improvement in surface texture, and overall cosmetic outcome(black arrow).

Keloid

CO2 laser therapy has emerged as a useful adjunct in the management of keloids in the pediatric population, particularly in lesions that are bulky, symptomatic, or refractory to conventional treatments.4 The CO2 laser, owing to its high affinity for water, allows precise ablation or excision of keloid tissue with excellent hemostasis, minimal collateral thermal damage, and improved operative field visibility—an important consideration in children.

In pediatric keloids, CO2 laser is commonly employed in a fractional or excisional mode, often combined with adjuvant therapies such as intralesional corticosteroids, 5-fluorouracil, or pressure therapy to reduce the high risk of recurrence.37,38 Advantages in children include reduced procedure time, less intraoperative bleeding, faster wound healing, and potentially improved cosmetic outcomes compared to cold steel excision [Figures 5a and b].

(a and b) CO2 laser ablation for keloid (a) Pre-treatment clinical photograph of a 16-year-old patient showing a well-defined, firm, keloid over back, extending beyond the original wound margins. (b) Post-treatment image after 4 sessions of fractional CO2 laser (10,600 nm; energy 20–30 mJ/microbeam; density 5–10%; single pass) demonstrating reduction in keloid size and erythema with improvement in texture and pliability.
Figure 5: (a and b) CO2 laser ablation for keloid (a) Pre-treatment clinical photograph of a 16-year-old patient showing a well-defined, firm, keloid over back, extending beyond the original wound margins. (b) Post-treatment image after 4 sessions of fractional CO2 laser (10,600 nm; energy 20–30 mJ/microbeam; density 5–10%; single pass) demonstrating reduction in keloid size and erythema with improvement in texture and pliability.

Acne scars (Older children/adolescents)

Non-ablative fractional erbium-glass lasers (1550 nm) and CO2 lasers show strong efficacy in treating atrophic acne scars, with most patients achieving 50–75% improvement after 2–6 monthly sessions and no significant pigmentary side effects, even in darker skin types [Figures 6a and b].

(Original figure created by the authors) Fractional CO2 laser for acne scars. (a) Pre-treatment image of a 17-year-old male showing multiple atrophic acne scars over the cheek. (b) Post-treatment image after 4 sessions of fractional CO2 laser (10,600 nm; energy 20–30 mJ; density 10–15%; 1–2 passes) demonstrating improvement in scar depth, skin texture, and facial contour.
Figure 6: (Original figure created by the authors) Fractional CO2 laser for acne scars. (a) Pre-treatment image of a 17-year-old male showing multiple atrophic acne scars over the cheek. (b) Post-treatment image after 4 sessions of fractional CO2 laser (10,600 nm; energy 20–30 mJ; density 10–15%; 1–2 passes) demonstrating improvement in scar depth, skin texture, and facial contour.

AGE-RELATED CONSIDERATIONS IN LASER TREATMENT

Pain, blistering, swelling, scarring, and dyspigmentation (post-inflammatory hypo- or hyperpigmentation) are the most common side effects of laser treatment in children. For example, in laser treatment of hypertrophic burn scars, pain (8.1%) and blistering (8.1%) were reported most commonly, while dyspigmentation was less frequent (~3%).38

A preoperative examination, a comprehensive review, and a detailed evaluation of the patient’s appropriateness for the operation should all be carried out by the laser practitioner before the surgery.39 Before the pediatric patient is judged suitable for the treatment, the following crucial variables must be taken into account during patient selection[Table 4].

Table 4: Key laser parameters in pediatric dermatology.
Indication Laser Wavelength (nm) Fluence Pulse Interval Key note
PWS PDL 585–595 7–9 J/cm2 0.45–1.5 ms 2–4 week First-line
IH PDL 595 5–12 J/cm2 0.45–1.5 ms 2–4 week ± propranolol
Nevus of Ota QS/PS Nd:YAG 1064 1–3 J/cm2 ns/ps 6–8 week Safer in dark skin
CALMs QS Nd:YAG 1064 1–2 J/cm2 ns 6–8 week Recurrence common
Lentigines QS Nd:YAG 532/1064 1–2 J/cm2 ns 4–6 week PIH risk
Tattoos QS/PS 532–1064 Variable ns/ps 6–8 week Multi-session
Warts PDL/Nd:YAG 595/1064 Variable ms 3–4 week Vascular target
Scars Fractional 1550 Device-based NA 4 week Non-ablative
Keloids CO2 10,600 15–30 mJ NA 4 week ±steroids
Acne scars Fractional/CO2 1550/10,600 Device-based NA 4 week Gradual response

QS: Q-switched, PS: Picosecond, PDL: Pulsed dye lasers, PWS: Port-wine stains, IH: Infantile hemangiomas, CALMs: Café-au-lait macule, PIH: Post-inflammatory hyperpigmentation, NA: Not available, ms: Millisecond, ns: Nanosecond, ps: Picosecond

Child’s age, maturity, and cognitive development pediatric patients range in age from 0 to 18, and every stage of childhood has its own set of factors to take into account. For example, children older than three may be less cooperative, and swaddling may be difficult, in contrast to newborns.40 On the other hand, teenagers are more likely than infants to cooperate during the process.

Psychosocial elements

Even though the majority of birthmarks are benign, their esthetic appeal may have a detrimental psychological effect on the kid, depending on their kind, magnitude, and anatomical position.41,42 As a result, this is a crucial consideration for determining the child’s appropriate procedure age.5 Therefore, it is best to treat potentially stigmatising birthmarks as soon as feasible.

Anesthesia topical

Most of the time, topical anesthetics are employed. Under occlusion, eutectic mixture of local anesthetics (EMLA) cream—a eutectic combination of 2.5% lidocaine and 2.5% prilocaine—is frequently used in small doses. Although it is typically well tolerated and effective, the dosage needs to be modified according to the application area and should not exceed 1 g/10 cm2.43,44

Special precautions must be used while applying EMLA cream to pediatric patients’ skin in order to restrict the dosage and application area and to avoid unintentional swallowing of the occlusive dressing or the cream.43,44 A supplementary protective covering, such as gauze or a bandage, may occasionally be helpful to avoid unintentionally disturbing the application site. Even while EMLA is well tolerated, it might cause typical adverse effects such as edema, pallor, and erythema. Systemic problems like methemoglobinemia and systemic toxicity might happen seldom.43,45

Furthermore, following EMLA administration for dermatological operations as well as other procedures such lumbar puncture, circumcision, and central vein insertion, incidences of methemoglobinemia in children have been documented.46 These occur when vulnerable patients are exposed to large amounts of prilocaine.

Adjunctive measures, including cooling devices, vibration, and distraction techniques, further help reduce pain and improve cooperation. Sedation or general anesthesia (GA) may be considered for extensive procedures, sensitive anatomical sites, or uncooperative children; however, repeated exposure should be minimized due to potential neurodevelopmental concerns.

Pre-procedure evaluation should include assessment of comorbidities, airway risk, and prior anesthetic history. Continuous monitoring during the procedure and adherence to pediatric dosing guidelines are essential to ensure safety while optimizing treatment outcomes.

SAFETY AND RISK MANAGEMENT

Other mitigating variables for these frequent laser-related problems in the pediatric population [Flowchart 2], aside from cautious patient selection, include [Table 5].

Safety and optimization algorithm for pediatric laser therapy. Illustrates key steps in pre-treatment assessment, parameter selection, intra-procedural precautions, complication prevention, and follow-up to ensure safe and effective laser use in children.
Flowchart 2: Safety and optimization algorithm for pediatric laser therapy. Illustrates key steps in pre-treatment assessment, parameter selection, intra-procedural precautions, complication prevention, and follow-up to ensure safe and effective laser use in children.
Table 5: Common adverse effects and preventive strategies.
Adverse effect Frequency Risk factors Prevention
Pain High Low threshold in children Topical anesthesia, cooling devices
Epidermal damage Moderate Higher fluence, darker skin Test spot, cooling, conservative settings
Dyspigmentation Moderate–high Fitzpatrick IV–VI Lower fluence, sun protection, topical steroids
Infection (HSV, bacteria) Low–moderate Facial/perioral treatment, prior HSV Oral antiviral prophylaxis, aseptic technique
Eye injury Rare Lack of eye protection Mandatory goggles/shields

HSV: Herpes simplex virus

Pain

Compared to adults, children often have a lower pain threshold. Other pain management methods, such as cooling packs and vibrating devices, can be used in addition to anesthesia (as mentioned above) to reduce discomfort and calm the affected region.47,48 An aide can also use distraction strategies to help the patient relax.

Infection risk

The skin barrier may be momentarily compromised by laser therapy, increasing the risk of infection. Herpes simplex virus (HSV) infections have been documented following laser treatment, particularly in relation to face and/or perioral treatments. In addition, HSV reactivation may manifest as impetiginization or secondary bacterial infection, which might raise the risk of scarring and pigmentary alterations. Therefore, it’s critical to check for a history of HSV infection in every patient.49

Eye injury

Laser treatment has the potential to harm the eyes. Therefore, it’s critical to get the patient ready and provide the required protection.50 The procedure should not be carried out if the kid is not cooperative, unless GA or sedation is used, in which case the proper eye protection can be given.

REGIONAL AND ETHNIC CONSIDERATIONS

Asian skin and laser response

Asian skin (Fitzpatrick types III–V) has higher melanin content and a compact stratum corneum, making it more prone to pigmentary changes post-laser.51 In pediatric patients, active melanocytes and ongoing skin maturation further increase the risk of complications. Lasers with longer wavelengths (e.g., Nd:YAG 1064 nm) and conservative settings are preferred to reduce adverse effects.25

Pigmentary complications and tailored protocols

PIH) and hypopigmentation are common in Asian children after laser therapy. To minimize risks, treatment protocols should use lower fluence, longer pulse durations, and non-ablative lasers[Tables 5 and 6].52

Table 6: Safety protocols in pediatric laser therapy.
Phase Key measures Clinical details
Pre-procedure Patient evaluation Assess lesion type, depth, skin phototype
Risk assessment History of HSV, keloids, prior procedures
Test spot Recommended in Fitzpatrick IV–VI
Counseling Explain outcomes, sessions, complications
Prophylaxis Antivirals for HSV-prone patients
Anesthesia planning Topical versus sedation versus GA
Intra-procedure Eye protection Mandatory for patient and staff
Cooling Dynamic cooling device, contact, or air cooling
Laser settings Start low, avoid overlap
Passes Limit to 1–2 passes
Pain control Topical anesthesia, distraction
Patient control Avoid procedure if uncooperative without sedation
Post-procedure Skin care Emollients±topical antibiotics/ steroids
Photoprotection Sunscreen+sun avoidance
Monitoring Watch for PIH, blistering, infection
Follow-up Review before next session
Complication prevention PIH Low fluence, longer intervals
Infection Aseptic technique, antivirals
Scarring Conservative parameters
Eye injury Protective eyewear
Pediatric-specific considerations Parameter adjustment Lower fluence, longer pulse duration
Skin of color Prefer longer wavelengths (1064 nm)
Session planning Limit treatment area per session
Anesthesia safety Minimize repeated GA exposure

GA: General anesthesia, HSV: Herpes simplex virus, PIH: Post-inflammatory hyperpigmentation

Pre- and post-treatment care, including sun protection and topical agents, is essential. Individualized protocols and gradual escalation improve safety and outcomes.

Cultural attitudes and access to pediatric laser care

In many Asian communities, cultural beliefs may delay seeking laser care for children, despite concerns about visible lesions. Access is limited by cost, lack of pediatric-specific services, and parental hesitancy. Improved education, affordability, and trained personnel are needed to expand safe pediatric laser access in Asia.

RECENT ADVANCES AND EMERGING TECHNOLOGIES

Fractional lasers in pediatric indications

Fractional lasers, especially non-ablative types (e.g., 1550 nm erbium-glass), are increasingly used in children for scars, burns, striae, and genodermatoses (e.g., xeroderma pigmentosum).53 They create controlled microthermal zones, enabling safer healing with lower risk of pigmentary changes in darker skin types. Their minimal downtime and favorable safety profile make them suitable for pediatric use, often under topical anesthesia or mild sedation.

Use of combined laser modalities

Combining laser types enhances treatment outcomes in complex lesions. For example, PDL plus fractional CO2 improves hypertrophic scars, and QS Nd:YAG with fractional lasers aids in nevus of Ota.54 Combination protocols allow targeting multiple chromophores or tissue depths in fewer sessions, improving efficacy while reducing energy per device and minimizing side effects.55

Integration with other therapies

Lasers are increasingly integrated with pharmacologic treatments. For IH, early PDL may complement oral propranolol in treating superficial components or residual redness.56 In scars or epidermal nevi, combining lasers with topical retinoids or intralesional steroids enhances response. This multimodal approach offers synergistic benefits and reduces the need for aggressive laser settings.

LIMITATIONS AND RESEARCH GAPS

Need for long-term safety data

Despite increasing use of lasers in children, long-term safety data—particularly regarding growth, pigmentation, and scarring—remain limited. Concerns persist about cumulative thermal damage and effects on developing skin structures. Longitudinal studies are needed to assess delayed adverse outcomes and optimize treatment timing.

Lack of standardized pediatric laser treatment protocols

Currently, pediatric laser treatments are largely extrapolated from adult protocols, lacking standardized guidelines. Variability in device settings, sedation approaches, and follow-up care contributes to inconsistent outcomes. The development of age- and skin-type-specific protocols is crucial for safe, reproducible treatment.

Underrepresentation of pediatric populations in laser studies

Children remain underrepresented in clinical trials on laser therapies. Ethical concerns, limited access to pediatric laser centers, and lack of funding contribute to this gap. Increasing pediatric inclusion in well-designed studies is essential to establish evidence-based practices tailored to younger patients.

Key clinical recommendations

  • Pediatric laser therapy requires a conservative, stepwise approach with gradual parameter escalation

  • PDL is first-line for vascular lesions, with best outcomes when initiated early

  • QS and PS lasers are preferred for pigmented lesions, especially dermal melanocytosis

  • Longer wavelengths (1064 nm) and lower fluence improve safety in skin of color

  • Fractional lasers are effective for scars, while CO2 laser with adjuvants is useful for keloids

  • Topical anesthesia and cooling are usually sufficient; GA should be minimized

  • Strict photoprotection, eye safety, and post-procedure care are essential to prevent complications

  • Combination therapies enhance outcomes in resistant or complex lesions.

CONCLUSION

Laser therapy has emerged as a valuable tool in pediatric dermatology, offering effective and minimally invasive options for a wide range of vascular, pigmented, and scarring conditions. However, pediatric patients are not merely “small adults;” their distinct anatomical, physiological, and psychological profiles necessitate individualized, age-appropriate, and culturally sensitive approaches. Asian pediatric skin types present additional challenges due to increased melanin content and a higher risk of pigmentary complications, requiring tailored laser parameters and careful post-procedure care.

Recent advances, such as fractional lasers, combination laser protocols, and integration with pharmacologic treatments such as propranolol, have expanded the therapeutic armamentarium, yet the field continues to face limitations. The lack of long-term safety data, the absence of standardized pediatric protocols, and the underrepresentation of children in clinical trials highlight the urgent need for focused research and consensus guidelines.

Moving forward, collaborative multicenter studies, development of pediatric-specific safety algorithms, and inclusion of children in clinical research are critical to optimizing outcomes. Ultimately, the goal remains to deliver safe, effective, and equitable laser care that enhances both dermatologic and psychosocial well-being in pediatric patients.

Authors’ contributions:

Rashmi Sarkar: Conceptualization, supervision, critical review of literature, interpretation of data, writing—review and editing, and overall manuscript supervision. Manavi Gupta: Literature search, data curation, literature synthesis, drafting of the manuscript, preparation of tables and figures, writing—original draft preparation, and manuscript revision. Both authors contributed to the conception and design of the review, critically revised the manuscript for important intellectual content, approved the final version for publication

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for their images and other clinical information to be reported in the journal. The patient understand that the patient’s names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript, and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. . Applications of the Laser. 2018 Available from: https://www.taylorfrancis.com/books/9781351078269 [Last accessed on 2025 Jul 30]
    [CrossRef] [Google Scholar]
  2. , . Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524-7.
    [CrossRef] [PubMed] [Google Scholar]
  3. . Update on pediatric dermatologic surgery from tots to teens. Curr Opin Pediatr. 2014;26:452-9.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , . Laser therapy in dermatology: Kids are not just little people. Clin Dermatol. 2015;33:681-6.
    [CrossRef] [PubMed] [Google Scholar]
  5. , . Our approach to pediatric dermatologic laser surgery. Lasers Surg Med. 2005;37:255-63.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , . Skin maturation from birth to 10 years of age: Structure, function, composition and microbiome. Exp Dermatol. 2023;32:1420-9.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , . Infant skin physiology and development during the first years of life: A review of recent findings based on in vivo studies. Int J Cosmet Sci. 2011;33:17-24.
    [CrossRef] [PubMed] [Google Scholar]
  8. , . Postinflammatory hyperpigmentation: A review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3:20-31.
    [Google Scholar]
  9. , , , , . Successful and safe use of Q-switched lasers in the treatment of nevus of Ota in children with phototypes IV-VI. Lasers Surg Med. 2018;50:56-60.
    [CrossRef] [PubMed] [Google Scholar]
  10. . Wound healing in pediatrics. Nurs Clin North Am. 1990;25:181-92.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , . The 595-nm wavelength pulsed dye laser for pediatric port-wine birthmarks and infantile hemangiomas: A systematic review. Lasers Surg Med. 2025;57:27-36.
    [CrossRef] [PubMed] [Google Scholar]
  12. , . The incidence of birthmarks in the neonate. Pediatrics. 1976;58:218-22.
    [CrossRef] [Google Scholar]
  13. , , . Efficacy of early treatment of facial port wine stains in newborns: A review of 49 cases. Lasers Surg Med. 2007;39:563-8.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , , et al. Efficacy and safety evaluation of 595 nm pulsed dye laser treatment in 120 cases of Asian infants with port wine stain. Clin Cosmet Investig Dermatol. 2025;18:503-9.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , , , et al. Why do port-wine stains (PWS) on the lateral face respond better to pulsed dye laser (PDL) than those located on the central face? J Am Acad Dermatol. 2016;74:527-35.
    [CrossRef] [PubMed] [Google Scholar]
  16. , . Laser treatment in the management of infantile hemangiomas and capillary vascular malformations. Tech Vasc Interv Radiol. 2013;16:51-4.
    [CrossRef] [PubMed] [Google Scholar]
  17. , . Lasers for vascular lesions: Standard guidelines of care. Indian J Dermatol Venereol Leprol. 2011;77:349-68.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , , , et al. IADVL SIG pediatric dermatology (academy) recommendations on hemangioma of infancy (HOI) Indian Dermatol Online J. 2023;14:172-86.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , . Laser treatment of pediatric vascular lesions: Port wine stains and hemangiomas. J Am Acad Dermatol. 2008;58:261-85.
    [CrossRef] [PubMed] [Google Scholar]
  20. , . Targeted topical and combination laser surgery for the treatment of angiofibromas. Lasers Surg Med. 2013;45:555-7.
    [CrossRef] [PubMed] [Google Scholar]
  21. . Tissue Optics 1000 20th Street, Bellingham, WA 98227-0010. . USA: SPIE; Available from: https://ebooks.spiedigitallibrary.org/book.aspx?doi=10.1117/3.684093 [Last accessed on 2025 Aug 13]
    [Google Scholar]
  22. , , , , . Lasers and nevus of Ota: A comprehensive review. Lasers Med Sci. 2016;31:179-85.
    [CrossRef] [PubMed] [Google Scholar]
  23. , . Treatment of nevus of Ota with the Q-switched alexandrite laser. Lasers Surg Med. 2001;28:451-5.
    [CrossRef] [PubMed] [Google Scholar]
  24. , , , , , , et al. Comparison of a picosecond alexandrite laser versus a Q-switched alexandrite laser for the treatment of nevus of Ota: A randomized, split-lesion, controlled trial. J Am Acad Dermatol. 2020;83:397-403.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , , , , et al. Comparing the efficacy and safety of Q-switched and picosecond lasers in the treatment of nevus of Ota: A systematic review and meta-analysis. Lasers Med Sci. 2021;36:723-33.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , . Response to laser treatment of café au lait macules based on morphologic features. JAMA Dermatol. 2017;153:1158-61.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , . Laser treatment for cafe-au-lait macules: A systematic review and meta-analysis. Aesthetic Plast Surg. 2023;47:2235-47.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , . Optimising laser tattoo removal. J Cutan Aesthet Surg. 2015;8:16-24.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , , , . Clinical characteristics of Becker's nevus in children: Report of 118 cases from Italy. Pediatr Dermatol. 2012;29:571-4.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , . Evaluating the roles of different types of laser therapy in Becker's nevus treatment. J Clin Med. 2022;11:4230.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , , , . A retrospective analysis on the management of pigmented lesions using a picosecond 755-nm alexandrite laser in Asians. Lasers Surg Med. 2016;48:23-9.
    [CrossRef] [PubMed] [Google Scholar]
  32. , , , , . Efficacy and safety of long-pulse pulsed dye laser delivered with compression versus cryotherapy for treatment of solar lentigines. Indian J Dermatol. 2011;56:48-51.
    [CrossRef] [PubMed] [Google Scholar]
  33. , , , , . Efficacy and safety of Q-switched neodymium-doped yttrium aluminum garnet (532 nm) in freckles in skin of color patients. JCAS. 2025;18:273.
    [CrossRef] [Google Scholar]
  34. , , . Pulsed dye laser therapy in the treatment of warts: A review of the literature. Dermatol Surg. 2017;43:485-93.
    [CrossRef] [PubMed] [Google Scholar]
  35. , , , . Our experience using 1064 nm Nd: YAG in palmoplantar warts. J Cosmet Laser Ther. 2022;24:28-32.
    [CrossRef] [PubMed] [Google Scholar]
  36. , , , , . Fractional photothermolysis for the treatment of surgical scars: A case report. J Cosmet Laser Ther. 2006;8:35-8.
    [CrossRef] [PubMed] [Google Scholar]
  37. , , , . Second-generation 1,550-nm fractional photothermolysis for the treatment of acne scars. Dermatol Surg. 2008;34:1327-32.
    [CrossRef] [PubMed] [Google Scholar]
  38. , , , . Treatment of hypertrophic burn scars with laser therapy: A review of adverse events. Ann Plast Surg. 2023;91:715-9.
    [CrossRef] [PubMed] [Google Scholar]
  39. , , , . Current practices in pediatric dermatology laser therapy: An international survey. Lasers Surg Med. 2021;53:946-52.
    [CrossRef] [PubMed] [Google Scholar]
  40. , , , , , . Laser surgery in pediatric skin of color patients: A systematic review. Pediatr Dermatol. 2025;42:700-15.
    [CrossRef] [PubMed] [Google Scholar]
  41. , , . Paediatric vascular birthmarks-the psychological impact and the role of the GP. Aust Fam Physician. 2009;38:169-71.
    [Google Scholar]
  42. , . The psychosocial impact of an infantile haemangioma on children and their parents. Arch Dis Child. 2012;97:922-6.
    [CrossRef] [PubMed] [Google Scholar]
  43. , . Risk of systemic toxicity with topical lidocaine/prilocaine: A review. J Drugs Dermatol. 2014;13:1118-22.
    [Google Scholar]
  44. , , , , , , et al. Optimizing pediatric periprocedural pain management part I-Evolving ethics and topical anesthetics. Pediatr Dermatol. 2024;41:577-87.
    [CrossRef] [Google Scholar]
  45. , , , . Seizures and methemoglobinemia in an infant after excessive EMLA application. Pediatr Emerg Care. 2013;29:377-9.
    [CrossRef] [PubMed] [Google Scholar]
  46. , , . Acquired methemoglobinemia in an infant: Consequence of prolonged application of eutectic mixture of local anesthetics (EMLA) cream for spontaneous abscess drainage. Cureus. 2022;14:e31304.
    [CrossRef] [Google Scholar]
  47. , , , , , . Using vibrating and cold device for pain relieves in children: A systematic review and meta-analysis of randomized controlled trials. J Pediatr Nurs. 2021;61:23-33.
    [CrossRef] [PubMed] [Google Scholar]
  48. , , , , , , et al. Association between a single general Anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA. 2016;315:2312-20.
    [CrossRef] [PubMed] [Google Scholar]
  49. , . Herpes simplex virus prophylaxis with famciclovir in patients undergoing aesthetic facial CO2 laser resurfacing. Cutis. 2003;72:327-8.
    [Google Scholar]
  50. . Dermatologic laser-induced ocular and periocular complications: A review. BMC Ophthalmol. 2023;23:419.
    [CrossRef] [PubMed] [Google Scholar]
  51. , , , , , . Theoretical review of the treatment of pigmented lesions in Asian skin. Laser Ther. 2016;25:179-84.
    [CrossRef] [PubMed] [Google Scholar]
  52. , , , , . Advancements in laser therapies for dermal hyperpigmentation in skin of color: A comprehensive literature review and experience of sequential laser treatments in a cohort of 122 Indian patients. J Clin Med. 2024;13:2116.
    [CrossRef] [PubMed] [Google Scholar]
  53. , , , . Non-ablative 1550 nm erbium-glass and ablative 10,600 nm carbon dioxide fractional lasers for various types of scars in Asian people: Evaluation of 100 patients. Photomed Laser Surg. 2014;32:42-6.
    [CrossRef] [PubMed] [Google Scholar]
  54. , , . Nevus of Ota: Combination treatment with Q-switched neodymium-doped yttrium aluminum garnet laser and fractional CO2 laser. J Cutan Aesthet Surg. 2023;16:214-20.
    [CrossRef] [PubMed] [Google Scholar]
  55. , , , . Efficacy of pulsed dye laser combined with fractional CO2 laser in the treatment of pediatric burn scars. Lasers Surg Med. 2023;55:464-70.
    [CrossRef] [PubMed] [Google Scholar]
  56. , , . Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma. Anal Pediatr. 2016;84:92-6.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections